Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.800 | 1.000 | 14 | 2002 | 2015 | |||||
melanoma
|
515 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.720 | 1.000 | 9 | 2002 | 2016 | |||||
Neoplasms
|
1644 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.780 | 0.778 | 9 | 2004 | 2019 | |||||
Cardio-facio-cutaneous syndrome
|
82 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.800 | 1.000 | 7 | 2006 | 2016 | |||||
Papillary thyroid carcinoma
|
204 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.070 | 0.857 | 7 | 2004 | 2019 | |||||
Noonan Syndrome
|
187 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 4 | 2007 | 2016 | |||||
Follicular adenoma
|
5 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2003 | 2018 | |||||
Follicular thyroid carcinoma
|
28 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2011 | 2016 | |||||
Follicular Variant Thyroid Gland Papillary Carcinoma
|
13 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2015 | |||||
Neoplasm Metastasis
|
327 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
Secondary Neoplasm
|
85 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
Thyroid Gland Follicular Adenoma
|
14 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2003 | 2016 | |||||
Thyroid Neoplasm
|
135 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.710 | 1.000 | 2 | 2016 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Adenocarcinoma of prostate
|
108 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Adenomatous Polyposis Coli
|
237 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Carcinoma, Papillary
|
9 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Chronic Lymphocytic Leukemia
|
291 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Cutaneous Melanoma
|
248 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Follicular neoplasm
|
5 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Gastric Adenocarcinoma
|
235 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Metastatic melanoma
|
42 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2002 | 2002 |